MercyOne Waterloo participating in a clinical trial for COVID-19 treatment
Researchers are looking at a monoclonal antibody known as “CSL312.” The clinical trial will target patients who have severe COVID-19 symptoms and …
Source: MercyOne Waterloo participating in a clinical trial for COVID-19 treatment